Clicky

 

Intelligence » Cystic Fibrosis » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

Corbus Plans to Start Phase 2b Trial of Its Cystic Fibrosis Therapy Anabasum by Year’s End

Thursday, August 17, 2017 -- Corbus Pharmaceuticals plans to start a Phase 2b clinical trial of anabasum as a cystic fibrosis treatment by the end of 2017. The decision follows positive results of a Phase 2 study, the company said. Anabasum was formerly known as JBT-101 or Resunab. A Phase 2a trial usually looks at a drug’s effectiveness in a small number of patients, while the goal […] The post Corbus Plans to Start Phase 2b Trial of Its Cystic Fibrosis Therapy Anabasum by Year’s End appeared first on Cystic Fibrosis News Today.